The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say made insulin prices soar.
The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback